Mori Shigemi, Horita Akira, Ginnaga Akihiro, Miyatsu Yoshinobu, Sawabe Kyoko, Matsumura Takayuki, Ato Manabu, Yamamoto Akihiko, Shibayama Keigo, Arai Satoru, Yamagishi Takuya, Takahashi Motohide, Taki Hisashi, Hifumi Toru
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN).
National Institute of Infectious Diseases.
Jpn J Infect Dis. 2017 Nov 22;70(6):635-641. doi: 10.7883/yoken.JJID.2017.125. Epub 2017 Oct 31.
This is the first report on large-scale experimental production of an equine antivenom against the redback spider (Latrodectus hasseltii) lived in Japan. We captured 10,000 redback spiders in Japan and prepared the toxoids of crude venom extract, mixed the toxoids with a mineral oil adjuvant, and immunized healthy horses repeatedly over a period of several weeks. Thereafter, we separated the horse plasma, purified the γ-globulin fraction, and stocked it as a purified antivenom concentrate. Consequently, we manufactured approximately 6,500 vials of a single-dose freeze-dried test lot from a portion of the purified γ-globulin fraction, equivalent to the extract derived from 520 spiders. This test lot had an antitoxin titer comparable to that of a similar drug commercially available overseas (a liquid preparation), and the other quality met all quality reference specifications based on the Minimum Requirements for Biological Products and other guidelines relevant to existing antivenom drug products in Japan.
这是关于在日本大规模实验生产针对红背蜘蛛(寇蛛)的马抗蛇毒血清的首份报告。我们在日本捕获了10000只红背蜘蛛,制备粗毒提取物类毒素,将类毒素与矿物油佐剂混合,并在数周内反复免疫健康马匹。此后,我们分离马血浆,纯化γ球蛋白组分,并将其作为纯化抗蛇毒血清浓缩物储存。因此,我们从一部分纯化的γ球蛋白组分中制备了约6500瓶单剂量冻干试验批次,相当于来自520只蜘蛛的提取物。该试验批次的抗毒素效价与海外市售类似药物(液体制剂)相当,其他质量符合基于《生物制品最低要求》及日本现有抗蛇毒药物产品相关其他指南的所有质量参考规范。